-
Je něco špatně v tomto záznamu ?
Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction
L. Monzo, M. Tupy, BA. Borlaug, A. Reichenbach, I. Jurcova, J. Benes, L. Mlateckova, J. Ters, J. Kautzner, V. Melenovsky
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
NV19-02-00130
Ministerstvo Zdravotnictví Ceské Republiky
NU21-02-00402
Ministerstvo Zdravotnictví Ceské Republiky
NU22-02-00161
Ministerstvo Zdravotnictví Ceské Republiky
LX22NPO5104
National Institute for Research of Metabolic and Cardiovascular Diseases
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2014
PubMed Central
od 2015
Europe PubMed Central
od 2015
ProQuest Central
od 2014-09-01
Open Access Digital Library
od 2014-09-01
Open Access Digital Library
od 2014-01-01
Health & Medicine (ProQuest)
od 2014-09-01
Wiley-Blackwell Open Access Titles
od 2014
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
38263857
DOI
10.1002/ehf2.14682
Knihovny.cz E-zdroje
- MeSH
- dysfunkce levé srdeční komory * MeSH
- echokardiografie metody MeSH
- funkce levé komory srdeční MeSH
- lidé MeSH
- srdeční komory diagnostické zobrazování MeSH
- srdeční selhání * MeSH
- tepový objem MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: The determinants and relevance of right ventricular (RV) mechanical dyssynchrony in heart failure with reduced ejection fraction (HFrEF) are poorly understood. We hypothesized that increased afterload may adversely affect the synchrony of RV contraction. METHODS AND RESULTS: A total of 148 patients with HFrEF and 36 controls underwent echocardiography, right heart catheterization, and gated single-photon emission computed tomography to measure RV chamber volumes and mechanical dyssynchrony (phase standard deviation of systolic displacement timing). Exams were repeated after preload (N = 135) and afterload (N = 15) modulation. Patients with HFrEF showed higher RV dyssynchrony compared with controls (40.6 ± 17.5° vs. 27.8 ± 9.1°, P < 0.001). The magnitude of RV dyssynchrony in HFrEF correlated with larger RV and left ventricular (LV) volumes, lower RV ejection fraction (RVEF) and LV ejection fraction, reduced intrinsic contractility, increased heart rate, higher pulmonary artery (PA) load, and impaired RV-PA coupling (all P ≤ 0.01). Low RVEF was the strongest predictor of RV dyssynchrony. Left bundle branch block (BBB) was associated with greater RV dyssynchrony than right BBB, regardless of QRS duration. RV afterload reduction by sildenafil improved RV dyssynchrony (P = 0.004), whereas preload change with passive leg raise had modest effect. Patients in the highest tertiles of RV dyssynchrony had an increased risk of adverse clinical events compared with those in the lower tertile [T2/T3 vs. T1: hazard ratio 1.98 (95% confidence interval 1.20-3.24), P = 0.007]. CONCLUSIONS: RV dyssynchrony is associated with RV remodelling, dysfunction, adverse haemodynamics, and greater risk for adverse clinical events. RV dyssynchrony is mitigated by acute RV afterload reduction and could be a potential therapeutic target to improve RV performance in HFrEF.
Cardiovascular Division Mayo Clinic Rochester MN USA
Institute for Clinical and Experimental Medicine Prague Czech Republic
Université de Lorraine INSERM Centre d'Investigations Cliniques Plurithématique Nancy France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006575
- 003
- CZ-PrNML
- 005
- 20250305102224.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ehf2.14682 $2 doi
- 035 __
- $a (PubMed)38263857
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Monzo, Luca $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic $u Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique, Nancy, France $1 https://orcid.org/000000032958943X
- 245 10
- $a Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction / $c L. Monzo, M. Tupy, BA. Borlaug, A. Reichenbach, I. Jurcova, J. Benes, L. Mlateckova, J. Ters, J. Kautzner, V. Melenovsky
- 520 9_
- $a AIMS: The determinants and relevance of right ventricular (RV) mechanical dyssynchrony in heart failure with reduced ejection fraction (HFrEF) are poorly understood. We hypothesized that increased afterload may adversely affect the synchrony of RV contraction. METHODS AND RESULTS: A total of 148 patients with HFrEF and 36 controls underwent echocardiography, right heart catheterization, and gated single-photon emission computed tomography to measure RV chamber volumes and mechanical dyssynchrony (phase standard deviation of systolic displacement timing). Exams were repeated after preload (N = 135) and afterload (N = 15) modulation. Patients with HFrEF showed higher RV dyssynchrony compared with controls (40.6 ± 17.5° vs. 27.8 ± 9.1°, P < 0.001). The magnitude of RV dyssynchrony in HFrEF correlated with larger RV and left ventricular (LV) volumes, lower RV ejection fraction (RVEF) and LV ejection fraction, reduced intrinsic contractility, increased heart rate, higher pulmonary artery (PA) load, and impaired RV-PA coupling (all P ≤ 0.01). Low RVEF was the strongest predictor of RV dyssynchrony. Left bundle branch block (BBB) was associated with greater RV dyssynchrony than right BBB, regardless of QRS duration. RV afterload reduction by sildenafil improved RV dyssynchrony (P = 0.004), whereas preload change with passive leg raise had modest effect. Patients in the highest tertiles of RV dyssynchrony had an increased risk of adverse clinical events compared with those in the lower tertile [T2/T3 vs. T1: hazard ratio 1.98 (95% confidence interval 1.20-3.24), P = 0.007]. CONCLUSIONS: RV dyssynchrony is associated with RV remodelling, dysfunction, adverse haemodynamics, and greater risk for adverse clinical events. RV dyssynchrony is mitigated by acute RV afterload reduction and could be a potential therapeutic target to improve RV performance in HFrEF.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a srdeční selhání $7 D006333
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a srdeční komory $x diagnostické zobrazování $7 D006352
- 650 _2
- $a echokardiografie $x metody $7 D004452
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 650 12
- $a dysfunkce levé srdeční komory $7 D018487
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tupy, Marek $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Borlaug, Barry A $u Cardiovascular Division, Mayo Clinic, Rochester, MN, USA
- 700 1_
- $a Reichenbach, Adrian $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic $7 xx0329561
- 700 1_
- $a Jurcova, Ivana $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Benes, Jan $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Mlateckova, Lenka $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Ters, Jiri $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Kautzner, Josef $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Melenovsky, Vojtech $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 773 0_
- $w MED00197251 $t ESC heart failure $x 2055-5822 $g Roč. 11, č. 2 (2024), s. 1097-1109
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38263857 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20250305102235 $b ABA008
- 999 __
- $a ok $b bmc $g 2080898 $s 1216342
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 11 $c 2 $d 1097-1109 $e 20240123 $i 2055-5822 $m ESC heart failure $n ESC Heart Fail $x MED00197251
- GRA __
- $a NV19-02-00130 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a NU21-02-00402 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a NU22-02-00161 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases
- LZP __
- $a Pubmed-20240412